Cardiovascular effects of obstructive sleep apnoea and effects of continuous positive airway pressure therapy: evidence from different study models

  • 0Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland.

|

|

Summary

This summary is machine-generated.

Obstructive sleep apnoea (OSA) causes cardiovascular issues like hypertension and major adverse cardiovascular events (MACE). Continuous positive airway pressure (CPAP) therapy can lower blood pressure and reduce MACE risk, especially with good adherence.

Area Of Science

  • Cardiology
  • Sleep Medicine
  • Public Health

Background

  • Obstructive sleep apnoea (OSA) is linked to significant cardiovascular consequences.
  • Continuous positive airway pressure (CPAP) therapy is a primary treatment for OSA.
  • Decades of research explored OSA's cardiovascular impact and CPAP's efficacy, yielding sometimes conflicting results.

Purpose Of The Study

  • To synthesize evidence on cardiovascular outcomes in OSA patients.
  • To evaluate the effects of CPAP therapy on blood pressure, endothelial function, and MACE.
  • To discuss the level of evidence from various study designs.

Main Methods

  • Conducted a literature search in PubMed up to September 2023.
  • Included randomized controlled trials, meta-analyses, population-based studies, and OSA cohort studies.
  • Focused on cardiovascular endpoints: blood pressure, arterial hypertension, endothelial function, and MACE.

Main Results

  • High-level evidence confirms OSA's causal link to hypertension and endothelial dysfunction.
  • Untreated OSA is associated with higher MACE incidence in specific patient subgroups.
  • CPAP's blood pressure-lowering effect is most notable in resistant hypertension; MACE risk reduction hinges on CPAP adherence.

Conclusions

  • Cardiovascular risks in OSA are influenced by severity, symptoms, phenotype, and comorbidities.
  • Younger patients with severe OSA and hypoxemia may particularly benefit from CPAP for cardiovascular risk reduction.
  • Further randomized controlled trials are needed for CPAP's role in primary cardiovascular prevention and high-risk populations.

Related Concept Videos

Sleep Apnea 01:21

120

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...

Mechanical Ventilation III: Noninvasive Ventilation 01:23

66

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure 01:16

151

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

Other Pulmonary Disorders 01:17

789

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

Chronic Obstructive Pulmonary Disease 01:22

1.1K

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Physiological Control of Respiration 01:23

1.8K

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...